Figure 6
From: Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen
In stage I patients, reduced PTEN expression has even stronger association with shorter relapse-free survival (a,b) and disease-specific survival (c,d) particularly in patients with tumors weakly positive for ER-α (10–50% positive cells) (a,c).
